SCNI (Scinai Immunotherapeutics) Cyclically Adjusted FCF per Share: $-132.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SCNI Scinai Immunotherapeutics Ltd SCNI
20 GF Score
Price $0.23
! 4 Warning Signs
View Full Analysis

What is Scinai Immunotherapeutics Cyclically Adjusted FCF per Share?

Scinai Immunotherapeutics SCNI -6.92% 20 Cyclically Adjusted FCF per Share is $-132.00 as of Mar. 2026. GuruFocus rates SCNI with a GF Score™ of 20/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Scinai Immunotherapeutics's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.385. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-132.00 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-26), Scinai Immunotherapeutics's current stock price is $0.23. Scinai Immunotherapeutics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-132.00. Scinai Immunotherapeutics's Cyclically Adjusted Price-to-FCF of today is .


Scinai Immunotherapeutics  (NAS:SCNI) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Scinai Immunotherapeutics Cyclically Adjusted FCF per Share Related Terms


Scinai Immunotherapeutics Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Scinai Immunotherapeutics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scinai Immunotherapeutics Cyclically Adjusted FCF per Share Chart

Scinai Immunotherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -139.73 -135.77 0.00

Scinai Immunotherapeutics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -135.77 -134.98 -131.68 0.00 -132.00

SCNI vs ABPO, ISCO, ZVSA: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Scinai Immunotherapeutics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scinai Immunotherapeutics Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scinai Immunotherapeutics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Scinai Immunotherapeutics's Cyclically Adjusted Price-to-FCF falls into.


SCNI
20GF Score
Scinai Immunotherapeutics Ltd SCNI
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scinai Immunotherapeutics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scinai Immunotherapeutics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.385/330.2130*330.2130
=-0.385

Current CPI (Mar. 2026) = 330.2130.

Scinai Immunotherapeutics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 -25.176 238.132 -34.911
201606 -24.824 241.018 -34.011
201609 -6.529 241.428 -8.930
201612 -16.529 241.432 -22.607
201703 -15.976 243.801 -21.638
201706 -20.136 244.955 -27.144
201709 -22.880 246.819 -30.611
201712 -22.682 246.524 -30.382
201803 -71.092 249.554 -94.070
201806 -189.662 251.989 -248.538
201809 -41.431 252.439 -54.195
201812 -30.292 251.233 -39.815
201903 -69.631 254.202 -90.452
201906 -98.723 256.143 -127.271
201909 0.000 256.759 0.000
201912 0.000 256.974 0.000
202003 0.000 258.115 0.000
202006 -35.324 257.797 -45.247
202009 -29.341 260.280 -37.224
202012 -54.722 260.474 -69.373
202103 0.000 264.877 0.000
202106 -17.224 271.696 -20.934
202109 -13.441 274.310 -16.180
202112 -13.421 278.802 -15.896
202203 -8.742 287.504 -10.041
202206 -16.096 296.311 -17.938
202209 -10.164 296.808 -11.308
202212 -4.448 296.797 -4.949
202303 -9.460 301.836 -10.349
202306 -9.624 305.109 -10.416
202309 -4.780 307.789 -5.128
202312 -3.144 306.746 -3.385
202403 -2.890 312.332 -3.055
202406 -2.765 314.175 -2.906
202409 -2.419 315.301 -2.533
202412 -1.261 315.605 -1.319
202503 -0.544 319.799 -0.562
202506 -1.227 322.561 -1.256
202512 0.000 324.054 0.000
202603 -0.385 330.213 -0.385

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-132.00 mean?
Scinai Immunotherapeutics (SCNI) has a Cyclically Adjusted FCF per Share of $-132.00 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Scinai Immunotherapeutics and its competitors.
Is Scinai Immunotherapeutics' Cyclically Adjusted FCF per Share too high?
Scinai Immunotherapeutics' current Cyclically Adjusted FCF per Share is $-132.00. Overall, Scinai Immunotherapeutics has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Scinai Immunotherapeutics' Cyclically Adjusted FCF per Share compare to ABPO and ISCO?
Scinai Immunotherapeutics' Cyclically Adjusted FCF per Share of $-132.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Scinai Immunotherapeutics and its competitors. Scinai Immunotherapeutics's current Cyclically Adjusted FCF per Share is $-132.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scinai Immunotherapeutics stock overvalued right now?
Scinai Immunotherapeutics (SCNI) has a current Cyclically Adjusted FCF per Share of $-132.00. The current Cyclically Adjusted FCF per Share is $-132.00. Scinai Immunotherapeutics' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Scinai Immunotherapeutics (SCNI), the current Cyclically Adjusted FCF per Share is $-132.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scinai Immunotherapeutics Business Description

Address Hadassah Ein Kerem Campus, 2nd Floor, Jerusalem BioPark, Jerusalem, ISR
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
20GF Score

Get the complete analysis for SCNI

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.23
Price